DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

100 Afleveringen

1. DrugPatentWatch Week in Review

   Gepubliceerd: 22-3-2022
2. 2 Strategies to Grow Your Excipient Business by Tracking Drug Patents

   Gepubliceerd: 22-3-2022
3. Free Online Course on Drug Patents, Generic and Branded Drugs

   Gepubliceerd: 10-3-2022
4. DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform

   Gepubliceerd: 20-10-2021
5. DrugPatentWatch Custom Market Surveillance

   Gepubliceerd: 20-10-2021
6. Updating the DrugPatentWatch Biologics Module

   Gepubliceerd: 20-10-2021
7. Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades

   Gepubliceerd: 20-10-2021
8. Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review

   Gepubliceerd: 12-10-2021
9. Generic Portfolio Management, Partnering with Brands, and Staying Competitive

   Gepubliceerd: 4-10-2021
10. Upcoming workshop on generic portfolio management

    Gepubliceerd: 16-8-2021
11. DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management

    Gepubliceerd: 16-7-2021
12. Strategies for Pricing Generic Drugs

    Gepubliceerd: 8-6-2021
13. Free Course in Generic and Branded Drug Lifecycle Management

    Gepubliceerd: 3-6-2021
14. Stop paying your staff to make repetitive reports

    Gepubliceerd: 7-4-2021
15. Connecting Excipients with Drug Patents – New DrugPatentWatch module

    Gepubliceerd: 8-3-2021
16. Say ‘NO’ to Bad Contracts

    Gepubliceerd: 11-2-2021
17. The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA

    Gepubliceerd: 3-2-2021
18. DrugPatentWatch featured in Inc Magazine

    Gepubliceerd: 2-2-2021
19. Pharmaceutical procurement practice aspects

    Gepubliceerd: 7-1-2021
20. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet

    Gepubliceerd: 5-1-2021